Developmental and behavioral effects of prenatal primidone exposure in the rat

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 4, 1996, Pages 481-487

  Pizzi, William J ^a   Alexander, Thomas D ^a   Loftus, John T ^a  

^a NORTHEASTERN ILLINOIS UNIVERSITY   (United States)

Author keywords

neurobehavioral teratology; open field activity; phenobarbital; primidone; radial arm maze

Indexed keywords

PHENOBARBITAL; PRIMIDONE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BIRTH WEIGHT; BODY WEIGHT; FEMALE; FETUS DEVELOPMENT; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; TERATOLOGY;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BODY WEIGHT; EXPLORATORY BEHAVIOR; FEMALE; GROWTH; MALE; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRIMIDONE; RATS; RATS, SPRAGUE-DAWLEY; REFLEX;

EID: 0030475833     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00247-X     Document Type: Article

References (40)

1. 1. Ardinger, H. H.; Atkin, J. F.; Blackston, R. D.; Elsas, L. J.; Clarren, S. K.; Livingstone, S.; Flannery, D. B.; Pellock, J. M.; Harrod, M. J.; Lammer, E. J.; Majewski, F.; Schnizel, A.; Toriello, H. V.; Hanson, J. W. Verification of the fetal valproate syndrome phenotype. Am. J. Med. Genet. 29:171-185; 1988.
2. 2. Bjerkedal, T.; Czeizel, A; Goujard, J.; Kallen, B.; Mastroiacova, P.; Nevin, N.; Oakley, G., Jr.; Roberts, E. Valproic acid and spina bifida. Lancet 2:1096; 1982.
3. 3. DiLiberti, J. H.; Farndon, P. A.; Dennis, N. R.; Curry, C. J. R. The fetal valproate syndrome. Am. J. Med. Genet. 19:473-481; 1984.
4. 4. Fisher, J. E.; Acuff-Smith, K. D.; Schilling, M. R.; Nau, H.; Vorhees, C. V. Trans-2-ene-valproic acid is leses behaviorally teratogenic than an equivalent dose of valproic acid in rats. Teratology 49:479-486; 1994.
5. 5. Fisher, J. E.; Vorhees, C. V. Developmental toxicity of antiepileptic drugs: Relationship to postnatal dysfunction. Pharmacol. Res. 26:207-221; 1992.
6. 6. Fishman, R. H. B.; Yanai, J. Long-lasting effects of early barbiturates on central nervous system and behavior. Neurosci. Biobehav. Rev. 7:19-28; 1983.
7. 7. Gupta, C.; Yaffe, S.; Shapiro, B. H. Prenatal exposure to phenobarbital permanently decreases testosterone and causes reproductive dysfunction. Science 216:640-642; 1982.
8. 8. Gupta, C.; Sonawane, B. R.; Yaffe, S. J. Phenobarbital exposure in utero: Alterations in female reproductive function in rats. Science 208:508-510; 1980.
9. 9. Hannah, R. S.; Roth, S. H.; Spira, A. W. The effects of chlorpromazine and phenobarbital on cerebellar Purkinje cells. Teratology 26:21-25; 1982.
10. 10. Hanson, J. W.; Myrianthopoulos, N. C.; Harvey, M. A. S.; Smith, D. W. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J. Pediatr. 89:662-668; 1976.
11. 11. Hanson, J. W.; Smith, D. W. The fetal hydantoin syndrome. J. Pediatr. 87:285-290; 1975.
12. 12. Harrell, L. E.; Barlow, T.; Parsons, D. Cholinergic neurons, learning, and recovery of function. Behav. Neurosci. 101:644-652; 1987.
13. 13. Harris, R. A.; Case, J. Effects of maternal consumption of ethanol, barbital, or chlordiazepoxide on the behavior of the offspring. Behav. Neurol. Biol. 26:234-247; 1979.
14. 14. Laviola, G.; Pick, C. G.,; Yanai, J.; Alleva, E. Eight-arm maze performance, neophobia, and hippocampal cholinergic alterations after prenatal oxazepam in mice. Brain Res. Bull. 29:609-616; 1992.
15. 15. Martin, J. C.; Martin, D. C.; Lemire, R.; Mackler, B. Effects of maternal absorption of phenobarbital upon rat offspring development and function. Neurobehav. Toxicol. 1:49-55; 1979.
16. 16. Martin, J. C.; Martin, D. C.; Mackler, B.; Grace, R.; Shores, P.; Chao, S. Maternal barbiturate administration and offspring response to shock. Psychopharmacology (Berlin) 85:214-220; 1985.
17. 17. McElhatton, P. R.; Sullivan, F. M.; Toseland, P. A. Teratogenic activity and metabolism of primidone in the mouse. Epilepsia 18: 1-17; 1977.
18. 18. Middaugh, L. D.; Santos, C. A. III; Zemp, J. W. Phenobarbital during pregnancy alters operant behavior of offspring in C57BL/6J mice. Pharmacol. Biochem. Behav. 3:1137-1139; 1975.
19. 19. Middaugh, L. D.; Santos, C. A. III; Zemp, J. W. Effects of phenobarbital given to pregnant mice on behavior of mature offspring. Dev. Psychobiol. 8:305-313; 1975.
20. 20. Middaugh, L. D.; Thomas, T. N.; Simpson, L. W.; Zemp, J. W. Effects of prenatal maternal injections of phenobarbital on brain neurotransmitters and behavior of young C57 mice. Neurotoxicol. Teratol. 3:271-275; 1981.
21. 21. Middaugh, L. D. Prenatal phenobarbital: Effects on pregnancy and offspring. In: Riley, E. P.; Vorhees, C. V., eds. Handbook of behavioral teratology. New York: Plenum Press; 1986:243-266.
22. 22. Morris, R. G. M.; Garrud, P.; Rawlins, J. N. P.; O'Keefe, J. Place navigation impaired in rats with hippocampal lesions. Nature 297: 681-683; 1982.
23. 23. Murai, N. Effect of maternal medication during pregnancy upon behavioral development of offspring. Tohuku. J. Exp. Med. 89: 265-272; 1966.
24. 24. Myhre, S. A.; Williams, R. Teratogenic effects associated with maternal primidone therapy. J. Pediatr. 99:160-162; 1981.
25. 25. Nyakas, C.; Endroczi, E. Learning and memory as a function of age and food deprivation in young rats. Acta Physiol. Acad. Sci. Hung. 41:163-173; 1972.
26. 26. Pick, C. G.; Yanai, J. Long-term reduction in eight-arm maze performance after early exposure to phenobarbital. Int. J. Dev. Neurosci. 3:223-227; 1985.
27. 27. Pizzi, W. J.; Jersey, R. M. Effects of prenatal diphenylhydantoin treatment on reproductive outcome, development, and behavior in rats. Neurotoxicol. Teratol. 14:111-117; 1992.
28. 28. Pizzi, W. J.; Olszanski, L. Behavioral teratology of anticonvulsant drugs: Carbamazepine. Teratology 39:505; 1989.
29. 29. Rating, D.; Jager-Roman, E.; Koch, S.; Nau, H.; Klein, P. D.; Helge, H. Enzyme induction in neonates due to antiepileptic therapy during pregnancy. In: Janz, D.; Dam, M.; Richens, A.; Bossi, L.; Helge, H; Schmidt, D., eds. Epilepsy, pregnancy, and the child. New York: Raven Press; 1982:349-355.
30. 30. Reinish, J. M.; Sanders, S. A. Early barbiturate exposure: The brain, sexually dimorphic behavior and learning. Neurosci. Biobehav. Rev. 6:311-319; 1982.
31. 31. Robert, E.; Rosa, F. Valproate and birth defects. Lancet 2:1142; 1983.
32. 32. Rogel-Fuchs, Y.; Newman, M. E.,; Trombka, D.; Zahalka, E. A.; Yanai, J. Hippocampal cholinergic alterations and related behavioral deficits after early exposure to phenobarbital. Brain Res. Bull. 29:1-6; 1992.
33. 33. Rosa, F. W. Spina bifida in infants of women treated with carbamazepine during pregnancy. N. Engl. J. Med. 324:674; 1991.
34. 34. Rudd, N. L.; Freedom, R. M. A possible primidone embryopathy. J. Pediatr. 94:835-837; 1979.
35. 35. Seip, M. Growth retardation, dysmorphic facies, and minor malformations following massive exposure to phenobarbitone in utero. Acta Pediatr. Scand. 65:617-621; 1976.
36. 36. Smith, D. B. Primidone: Clinical use. In: Levy, R.; Mattson, R.; Meldrum, B.; Penry, J. K.; Dreifuss, F. E., eds. Antiepileptic drugs, 3rd ed. New York: Raven Press; 1989:423-438.
37. 37. Vorhees, C. V. Fetal anticonvulsant syndrome in rats: Dose- and period-response relationships of prenatal diphenylhydantoin, trimethadione and phenobarbital exposure on the structural and functional development of the offspring. J. Pharmacol. Exp. Ther. 227:274-287; 1983.
38. 38. Vorhees, C. V. Fetal hydantoin syndrome in rats: Dose-effect relationships of prenatal phenytoin on postnatal development and behavior. Teratology 35:287-303; 1987.
39. 39. Vorhees, C. V. Teratogenicity and developmental toxicity of valproic acid in rats. Teratology 35:195-202; 1987.
40. 40. Vorhees, C. V. Behavioral teratogenicity of valproic acid: Selective effects on behavior after prenatal exposure to rats. Psychopharmacology 92:173-179; 1987.